Observational Studies in Veterinary Medicine: Strengths and Weaknesses

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Observational studies in veterinary medicine are crucial for investigating disease frequency, risk factors, and prognosis when experimental manipulation is impractical or unethical, with cross-sectional, cohort, and case-control designs offering distinct strengths for different research questions.
• Cross-sectional studies provide a snapshot for prevalence estimation and hypothesis generation, but are limited by temporal ambiguity and susceptibility to prevalence-incidence bias, making them unsuitable for establishing causal relationships (e.g., linking obesity to osteoarthritis).
• Cohort studies offer stronger causal inference by establishing temporal sequence, allowing direct estimation of incidence and relative risk, but are resource-intensive and vulnerable to loss to follow-up, particularly for diseases with long latent periods (e.g., tracking lameness incidence in dairy herds).
• Case-control studies are efficient for rare diseases or those with long latency by working backward from outcome to exposure, but are prone to selection and recall bias, necessitating careful selection of controls from the same source population (e.g., comparing feeding history in dogs with dilated cardiomyopathy).
• Confounding, arising from variables associated with both exposure and outcome (e.g., breed, age, management system), is a primary threat to causal inference in observational research, requiring strategies like restriction, matching, stratification, or multivariable regression for control.
• Transparent reporting, adhering to guidelines such as STROBE, is essential for critical appraisal of observational studies, enabling readers to assess design appropriateness, potential biases, and the generalizability of findings to different veterinary populations.

Observational studies form the backbone of veterinary clinical research where experimental manipulation is impractical, unethical, or prohibitively expensive. This article examines the principal observational designs used in veterinary medicine, their underlying logic, and their characteriztic strengths and limitations. It serves veterinary researchers who must select an appropriate design for a clinical question, appraise the published literature critically, or interpret observational evidence for practice decisions. The focus is on cross-sectional, cohort, and case-control studies as applied to companion animals, livestock, and wildlife populations.

Observational research answers questions about disease frequency, risk factors, prognosis, and diagnostic associations without assigning exposures or interventions. The investigator records what occurs in the population under study, whether the data are collected prospectively, retrospectively, or at a single point in time. This contrasts with experimental designs, where the investigator controls the allocation of exposure or treatment. The distinction matters because each approach carries different implications for causal inference, bias, and generalizability. Reporting standards for observational research, such as the STROBE guidelines catalogued by the EQUATOR Network reporting guideline library, provide a framework for transparent reporting and critical appraisal.

The choice of observational design follows directly from the research question, the temporal relationship between exposure and outcome, the rarity of the condition, and the resources available. A poorly matched design produces uninterpretable results regardless of the care taken in analysis. The sections that follow set out the design logic, the principal bias mechanisms, and the practical decision criteria that govern design selection in veterinary settings.

At a Glance

The Logic of Observational Design

Observational designs share a common logic: they exploit natural variation in exposure and outcome to estimate associations. The strength of the association, its consistency across populations, and the presence of a plausible biological mechanism determine whether an observed association supports a causal interpretation. No observational design can establish causation with certainty, because the investigator does not control confounding factors. The goal is to reduce the plausibility of alternative explanations through design choices and statistical adjustment.

The target population in veterinary research is usually a defined animal population, such as dairy herds in a region, dogs presented to primary care practices, or wildlife in a conservation area. The sampling frame must be specified precisely, because the validity of all subsequent inferences depends on how well the study sample represents the target population. Veterinary observational studies often rely on convenience samples drawn from hospital populations, which limits generalizability to the broader species population. The MSD Veterinary Manual professional reference notes that clinical findings from referral populations may not reflect primary care caseloads, a consideration that applies equally to observational research.

Cross-Sectional Studies

A cross-sectional study measures exposure and outcome simultaneously in a defined population at one point in time. This design is efficient for estimating disease prevalence and for describing the distribution of health-related characteriztics. In veterinary medicine, cross-sectional surveys are commonly used to estimate the prevalence of infectious agents in production systems, to characterize antimicrobial resistance patterns, and to describe the frequency of behavioral problems in companion animal populations.

The principal limitation is temporal ambiguity. Because exposure and outcome are measured at the same moment, the investigator cannot determine which came first. A cross-sectional association between obesity and osteoarthritis, for example, cannot distinguish whether obesity predisposes to joint disease or whether painful joints reduce activity and promote weight gain. This reverse causation problem limits the design's value for causal questions. Cross-sectional studies also systematically underrepresent animals with rapidly fatal diseases, because affected individuals may die before data collection, and overrepresent animals with chronic conditions. This prevalence-incidence bias distorts the association between exposure and outcome.

Cohort Studies

A cohort study follows a defined group of animals forward in time, recording exposures at baseline and monitoring for outcome development. The design permits direct estimation of incidence, relative risk, and attributable risk. Cohort studies are the strongest observational design for causal inference because the temporal sequence between exposure and outcome is known. The SPIROMICS investigation of airway mucins in chronic obstructive pulmonary disease exemplifies the cohort approach in human medicine, combining baseline characterization with three-year follow-up to examine disease initiation and progression SPIROMICS cohort analysis of airway mucins. Veterinary cohorts follow the same logic, whether tracking disease incidence in feedlot cattle, longevity in pedigree dogs, or recurrence rates after surgical treatment.

Prospective cohorts require substantial time and resources, particularly for diseases with long latent periods. Loss to follow-up is a persistent threat, because animals that leave the study may differ systematically from those that remain. A cohort of dogs monitored for hip dysplasia, for instance, may lose owners who move or who are dissatisfied with treatment outcomes, biasing the observed incidence. Retrospective cohorts use existing records to assemble the cohort and follow outcomes, reducing cost but introducing dependence on data quality and completeness. The ARRIVE reporting guidelines for animal research emphasize the need to report animal numbers and attrition transparently, a principle that applies to observational cohorts as much as to experimental studies.

Case-Control Studies

Case-control studies proceed backward from outcome to exposure. Cases are animals with the condition of interest, controls are animals without it, and the investigator compares historical exposure frequencies between the two groups. This design is efficient for rare diseases, conditions with long latency, and outbreaks where the population at risk is no longer intact.

The defining vulnerability is selection bias. Controls must arise from the same source population that produced the cases, and the sampling fraction for controls must be independent of exposure. In veterinary practice, the hospital population is the usual source, which means both cases and controls are drawn from animals that presented for care. A control group drawn from a first-opinion caseload may differ systematically from the general population in ways that distort exposure estimates. For production animal work, controls should be selected from herds or flocks with comparable management and disease pressure, not from unaffected herds that may differ in biosecurity, nutrition, or genetics.

Recall bias operates differently in veterinary medicine than in human research. Owners may remember exposures more vividly after a serious diagnosis, but they may also misattribute events, particularly for conditions with gradual onset. For food animals, treatment records and movement documentation provide more reliable exposure data than producer recall. Where records exist, they should be extracted before the owner is interviewed, so that the interview does not color interpretation of the written record.

Matching controls to cases on variables such as breed, age, sex, and farm is common, but overmatching removes the ability to study the matched variable as a risk factor. Match only on variables that are true confounders, not on variables that lie on the causal pathway between exposure and outcome. A matched analysis requires a conditional model, and unmatched analysis of matched data produces conservative estimates of effect.

Strengths and Weaknesses Across Designs

The choice among cross-sectional, cohort, and case-control designs depends on the research question, the frequency of the outcome, the time available, and the resources at hand. The table below summarizes the practical distinctions.

The odds ratio from a case-control study approximates the relative risk when the outcome is rare. When the outcome is common, the odds ratio overstates the relative risk, and the investigator should report the odds ratio as such instead of reinterpret it as a risk ratio.

Selection of the Appropriate Design

The outcome frequency drives the initial decision. For a condition with an incidence below roughly 5 percent in the source population, a cohort study would require an impractically large sample to accrue enough events. A case-control design is the rational choice. For outcomes that are common, such as postoperative wound complications in a referral hospital, a cohort design is feasible and provides stronger evidence for causality.

The latency of the outcome matters equally. A cohort study of a disease with a years-long subclinical phase, such as chronic valvular heart disease in Cavalier King Charles Spaniels, would require follow-up beyond the practical horizon of most funding cycles. A case-control design can compress that timeline by identifying prevalent cases and reconstructing exposure history. Conversely, for acute outcomes such as postoperative death, a short cohort study is straightforward and avoids the recall problems inherent in retrospective exposure assessment.

Production system changes the calculus. In dairy and swine operations, herd-level records, movement data, and slaughter checks provide exposure and outcome information that individual-owner recall cannot match. These records make retrospective cohort studies feasible in production settings where they would be impossible in companion animal practice. For wildlife and free-ranging populations, capture-recapture methods and repeated cross-sectional sampling are often the only practical options, and the investigator must accept the limitations of prevalence data.

Bias and Confounding in Observational Work

Confounding is the central threat to causal inference in observational studies. A confounder is a variable associated with both exposure and outcome that is not on the causal pathway. In veterinary studies, age, breed, sex, and management system are frequent confounders. A study associating raw meat diets with bacterial enteritis in dogs must account for the possibility that raw-fed dogs are also more likely to be exercised off-lead, boarded, or exposed to other dogs.

Restriction, matching, stratification, and multivariable regression are the standard control strategies. Restriction limits the study to a single level of the confounder, which improves internal validity at the cost of generalizability. Stratification and regression both require that the confounder be measured accurately, and residual confounding remains when measurement is imprecise. Propensity score methods are increasingly used in veterinary observational research to balance many covariates simultaneously, but they do not remove confounding by unmeasured variables.

Information bias arises from misclassification of exposure or outcome. Non-differential misclassification, where errors occur equally in both groups, biases effect estimates toward the null. Differential misclassification, where errors depend on group membership, can bias estimates in either direction and is more dangerous. Blinding outcome assessors to exposure status and exposure assessors to outcome status reduces differential misclassification, and this practice should be built into the protocol even when full blinding is impossible.

Reporting and Appraisal Standards

Observational veterinary studies should be reported against the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist, which specifies the minimum items for transparent reporting of cohort, case-control, and cross-sectional studies. The EQUATOR Network reporting guideline library hosts STROBE alongside extensions for specific designs and settings. For production animal research, the REFLECT statement provides additional items relevant to livestock and food animal studies.

The ARRIVE guidelines for reporting animal research apply to experimental studies, but their principles of transparent reporting, sample size justification, and explicit description of inclusion and exclusion criteria are equally relevant to observational work. A reader should be able to determine from the methods section exactly which animals were eligible, how they were recruited, how many were lost to follow-up, and how missing data were handled.

When appraising an observational study, the first question is whether the design matches the research question. A cross-sectional study cannot answer a question about disease causation, and a case-control study cannot estimate incidence. The second question is whether the comparison groups arose from the same source population. The third is whether the magnitude of effect, the precision of the estimate, and the potential for bias support a clinical decision. The MSD Veterinary Manual and AVMA practice resources provide species-specific context that helps the clinician judge whether study findings transfer to their own patient population, but neither substitutes for critical appraisal of the primary literature.

The WOAH terrestrial animal health standards are relevant when observational findings inform surveillance design or trade-related health certification. Studies that estimate disease prevalence or demonstrate freedom from infection in a population should be evaluated against the surveillance standards in the Terrestrial Code, which specify sensitivity, specificity, and confidence requirements for official recognition of health status.

Recognized Complications and Failure Modes

Observational studies fail in predictable ways. The most damaging failure is selection bias arising from the sampling frame. When the study population is drawn from a referral hospital, the case mix skews toward severe, chronic, or refractory disease. Detection depends on comparing the source population with the target population. If the referral population differs in disease severity, comorbidity burden, or prior treatment exposure, the effect estimates will not generalize. The discriminating check is a flow diagram that accounts for every animal from eligibility screening through final analysis, with reasons for exclusion quantified at each step.

Information bias operates more insidiously. Differential misclassification occurs when measurement error is associated with the outcome or exposure. In retrospective work, medical records often lack standardized entries for body condition score, pain assessment, or owner-reported signs. A clinician who knows the exposure status may record outcome measures differently. Blinding outcome assessors to exposure status, where feasible, reduces this risk. For questionnaire-based instruments, validation in the target species and setting is required before results can be interpreted. The Patient-Reported Outcomes Measurement Information System (PROMIS) depression item bank demonstrates the standard: items were validated for convergent validity and responsiveness in a prospective observational protocol before clinical use.

Loss to follow-up constitutes a third failure mode. In longitudinal designs, animals that drop out are rarely a random subset. Owners of animals that deteriorate may seek care elsewhere, while animals that recover may not return for scheduled rechecks. When follow-up completeness falls below 80 percent, the risk of attrition bias becomes material. The corrective action is to compare baseline characteriztics of completers and non-completers and to perform sensitivity analyzes under different assumptions about missing outcomes.

Common Errors and Corrective Actions

Less experienced investigators frequently conflate association with causation when interpreting observational results. A cross-sectional finding that hospitalized animals with low antioxidant concentrations have worse outcomes does not establish that depletion causes deterioration. The observational study of antioxidant status in acute respiratory distress syndrome illustrates the constraint: reduced plasma antioxidants and elevated lipid peroxidation products were documented over six days, but the design could not separate cause from consequence of critical illness. The corrective action is to state the research question in terms of association, prediction, or hypothesis generation, and to resist causal language in the abstract and conclusions.

A second recurring error is overmatching in case-control studies. Matching on variables that lie on the causal pathway between exposure and outcome removes the very association under investigation. Matching on disease duration when studying a prognostic factor, for example, attenuates the estimate toward the null. The corrective action is to match only on strong confounders that are not affected by the exposure, and to consider whether adjustment in the analysis would serve better than matching in the design.

A third error involves ignoring clustering. Animals from the same herd, kennel, or household are not independent observations. Failure to account for clustering produces confidence intervals that are too narrow and P values that are too small. Multilevel models or generalized estimating equations with cluster-robust variance should be specified in the analysis plan before data collection begins.

Limitations of the Current Evidence

The veterinary observational evidence base remains thinner than its human counterpart. Many published studies are small, single-center, and retrospective, with limited external validation. The SPIROMICS cohort analysis of airway mucins in chronic obstructive pulmonary disease shows what is possible in human medicine: a multicentre prospective cohort with standardized protocols, quantitative imaging, and longitudinal follow-up. No veterinary respiratory cohort of comparable scale and depth currently exists. Extrapolating human findings to veterinary patients requires caution, since species differences in anatomy, physiology, and disease expression are substantial.

Expert opinion still diverges on several points. The threshold at which an observational association justifies a change in clinical practice remains contested. Some argue that large, consistent, dose-response associations from multiple cohorts can support clinical decisions when randomised trials are impractical. Others maintain that the residual confounding inherent in observational work is too great to support therapeutic changes. The retrospective analysis of exaggeration in health-related science news found that causal claims and advice to change behavior frequently exceeded what the underlying correlational research supported. Veterinary clinicians should apply the same scrutiny to observational findings reported in the lay press or continuing education summaries.

Escalation and Referral

Most observational studies do not require regulatory oversight, but exceptions exist. Studies involving client-owned animals that impose more than minimal risk, that withhold standard care, or that collect biological samples beyond routine clinical purposes may require institutional animal care and use committee review. Investigators should consult their institutional ethics board early, since requirements vary by jurisdiction and institution.

Regulatory reporting obligations arise when an observational study identifies a suspected adverse event associated with a licensed veterinary product. Suspected adverse reactions should be reported to the relevant pharmacovigilance program, and the American Veterinary Medical Association practice resources provide guidance on reporting pathways in the United States. For notifiable diseases detected incidentally during data collection, reporting obligations follow the World Organization for Animal Health terrestrial animal health standards. Investigators should know the notifiable disease list for their region before beginning fieldwork.

Referral for specialist consultation is warranted when the study design involves complex sampling, advanced statistical methods, or diagnostic procedures outside the investigator's expertise. A veterinary epidemiologist or biostatistician should be consulted before data collection, not after. Laboratory involvement is required when assays must be validated for the target species, since transfer of human assays to veterinary samples without species-specific validation produces unreliable results.

Frequently Asked Questions

How do I choose between a cohort and case-control design when funding is limited?

Cohort studies require sustained follow-up and repeated measurements, which drive up cost. Case-control designs are more efficient for rare outcomes because you deliberately sample affected and unaffected animals from an existing population. If the outcome is common or the latent period is short, a prospective cohort may be more economical than it first appears, since you avoid the expense of verifying historical exposures. For rare diseases with long latency, case-control sampling from a well-characterized referral population is usually the pragmatic choice. When resources are severely constrained, a cross-sectional survey can generate hypotheses, but it cannot establish temporal sequence. Consult the EQUATOR Network reporting guidelines before finalising the design, since the reporting requirements often reveal feasibility problems early.

What can I do when diagnostic imaging or laboratory equipment is unavailable?

Use the most specific and sensitive test that the setting permits, and document the limitation explicitly in the methods. A field diagnosis based on physical examination and signalment may be acceptable for a pilot study, but it will introduce misclassification bias that narrows the detectable effect size. Consider storing samples for later batch analysis if a referral laboratory is accessible, and validate any field-side test against the reference standard in a subset of animals. For production species, the WOAH terrestrial animal health standards describe surveillance requirements that may inform sampling strategies when laboratory confirmation is delayed. State clearly in the limitations section how imperfect measurement could shift the observed associations toward or away from the null.

How does the choice of observational design differ between companion animals and production species?

Companion animal studies can exploit electronic medical records from single or multiple referral hospitals, enabling efficient case-control sampling and retrospective cohorts with long follow-up. Production species offer larger populations, defined cohorts, and controlled management systems, but losses to follow-up from culling and movement between herds complicate longitudinal designs. Regulatory and trade requirements may mandate certain surveillance approaches in food animals, and the AVMA practice resources provide guidance on professional obligations in clinical settings. In both contexts, the exposure of interest must be measurable with acceptable accuracy. For production species, group-level exposures such as feed batch or housing system are often easier to ascertain than individual-level exposures, which shifts the analysis toward cluster-level inference and requires appropriate variance adjustment.

What record-keeping standards should I maintain during an observational study?

Maintain a prospective analysis plan with dated entries, a master log of all screened and enrolled animals, and a version-controlled codebook for every variable. Record the date and reason for any protocol deviation, including animals lost to follow-up, and preserve raw data in a format that does not permit silent alteration. For studies involving experimental animals, the ARRIVE guidelines 2.0 specify the minimum information needed for transparent reporting, and following them during data collection is more efficient than reconstructing details afterward. Keep separate files for identifying information and study data to protect client confidentiality. If the study informs clinical decisions, document the evidence base in the medical record so that subsequent clinicians can assess how the findings were applied.

How should I explain observational study limitations to a referring veterinarian or practice owner?

Frame the explanation around what the study can and cannot support. State that an observed association does not prove causation, and give one concrete example of a plausible confounder relevant to their caseload. Explain that the study estimates the strength of association, usually as an odds ratio or hazard ratio, and that the confidence interval reflects precision. If the study is retrospective, note that exposure measurement may rely on records of variable quality. The MSD Veterinary Manual can provide species-specific background on the condition under study, which helps contextualise the findings. Emphasize that observational evidence is often the best available for naturally occurring disease, and that clinical decisions should integrate the study results with the individual patient's circumstances.

When is it acceptable to stop a prospective cohort early?

Stopping rules should be specified before enrollment begins. Early termination is defensible when the exposure produces harm that exceeds a predefined threshold, when the observed effect is so large that continuing would be unethical, or when the accrual rate is so low that the study cannot answer the question within a reasonable timeframe. A futility analysis may justify stopping when the conditional power falls below a preset level. Do not stop simply because the unadjusted analysis shows a significant association, since confounding may explain the finding. Document the decision process and the data that informed it, and report the early termination in the final manuscript. Consult the EQUATOR Network reporting guidelines for the specific checklist that applies to the design, since early stopping imposes additional reporting obligations.

Related Clinical & Scientific Guides

• Conducting Systematic Reviews of Veterinary Diagnostic Test Accuracy
• Bias in Veterinary Research: Types, Sources, and Mitigation
• Cluster Randomized Trials in Veterinary Research: Design and Analysis

References and Further Reading

• Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study.. 2014.
• Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.. 2021.
• Antioxidant status in patients with acute respiratory distress syndrome.. 1999.
• The association between exaggeration in health related science news and academic press releases: retrospective observational study.. 2014.
• Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.. 2020.
• Seizures and epileptiform activity in the early stages of Alzheimer disease.. 2013.
• ARRIVE Guidelines 2.0 for Reporting Animal Research. PLOS Biology, 2020.
• EQUATOR Network Reporting Guidelines. EQUATOR Network.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Evaluating Prognostic Factor Studies in Veterinary Medicine
• Conducting Pharmacovigilance Studies in Veterinary Medicine
• Designing Dose-Response Studies in Veterinary Pharmacology
• Appraising Diagnostic Accuracy Studies in Veterinary Medicine
• Cohort Studies in Veterinary Research: Design and Interpretation

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.